Searched for
WOCKHARDT EARNINGS
Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...- Behind India's Rs 5.5 lakh crore FII selloff lies a hidden list of 84 multibagger winnersForeign institutional investors have sold Indian stocks worth Rs 5.5 lakh crore. However, a hidden list reveals 84 stocks where FIIs have a...
- Ahead of Market: 10 things that will decide stock market action on FridayIndian equities witnessed sharp swings before ending lower amid expiry-day volatility and rising geopolitical concerns. Profit booking in b...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- CG Power's growth momentum strong, but valuation comfort missing: Sandip SabharwalCG Power expands its switchgear production, signaling strong demand in the power equipment sector. However, market expert Sandip Sabharwal ...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian benchmark indices ended higher after a volatile session, with late buying in heavyweight IT stocks lifting sentiment. Sensex gained ...
- Metals rally largely priced in, limited upside seen after strong cyclical run: Sandip SabharwalMarket expert Sandip Sabharwal advises caution, seeing stock-specific chances but limited broad market conviction. He notes Wockhardt's app...
- Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...
- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
- Aegis Logistics shares rally 4% as Q4 profit rises 45% YoY; Board recommends dividendAegis Logistics shares rose sharply after the company reported a 45% year-on-year rise in Q4 FY26 consolidated net profit to Rs 413 crore, ...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Geopolitical tensions keep markets nervous despite strong earnings: Dipan MehtaGeopolitical tensions, particularly the Iran crisis, are overshadowing strong corporate earnings, according to Dipan Mehta. While India Inc...
- Ahead of Market: 10 things that will decide stock market action on FridayIndian benchmark indices ended slightly lower amid weakness in FMCG, IT and banking stocks, while analysts highlighted improving technical ...
- Ahead of Market: 10 things that will decide stock market action on ThursdayDomestic equities surged as crude oil slipped below $100 and US-India trade optimism boosted sentiment. Nifty and Sensex gained over 1%, le...
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian markets closed lower amid selling in financial, consumer and realty stocks, with Nifty and Sensex declining. Technical indicators si...
- Smallcap winners! Wockhardt, Tata Tech, CAMS, other stocks rally up to 11% despite overall market weaknessSmallcap stocks outperformed on Tuesday despite weak broader markets, with Wockhardt, Tata Tech and CAMS gaining up to 11% on strong Q4 ear...
- Wockhardt shares jump 9% after strong Q4 turnaround, robust FY26 growthWockhardt shares saw a significant jump on Tuesday. The pharmaceutical company reported a strong turnaround in its March quarter performanc...
- Wockhardt hits 52-week high on strong Q2 resultsWockhardt Ltd surged over 4% in trade to hit its 52-week high of Rs 1784.90 on Thursday after the drug firm said its consolidated net profi...
- Wockhardt Q2 profit surges over three-fold to Rs 454 crWockhardt today said its consolidated net profit surged over three-fold to Rs 453.55 crore for the second quarter ended September 30, 2012.
Load More
